Given that this is a targeted panel there are no data on other potentially important homozygous deletions in myeloma, such as FAM46C and CYLD both of which have been shown to be biologically or clinically important.10, 12, 26, 27. This evidence concerns the gene CYLD and plasma cell myeloma.